Literature DB >> 11516720

Spindle poisons induce allelic loss in mouse lymphoma cells through mitotic non-disjunction.

M Honma1, M Momose, H Sakamoto, T Sofuni, M Hayashi.   

Abstract

Aneuploidy is an important contributor to reproductive failure and tumor development. It arises spontaneously or as a result of exposure to aneugenic agents through non-disjunction. Two spindle poisons, colchicine (COL) and vinblastine (VBL) are mutagenic in the mouse lymphoma assay (MLA), a gene mutation assay that targets the heterozygous thymidine kinase (tk) gene on chromosome 11 in mouse lymphoma L5178Y tk+/- 3.7.2c cells. To investigate the mechanisms of spindle poison mutagenesis, we analyzed the COL- and VBL-induced TK mutants at the molecular and cytogenetic level. Loss of heterozygosity (LOH) analysis employing a microsatellite region within the tk locus revealed that almost all mutants had lost the functional tk allele. To determine the extent of the LOH, we further examined LOH mutants for heterozygosity at nine microsatellite loci spanning the entire chromosome 11. Interestingly, every microsatellite marker showed LOH in all COL- and VBL-induced LOH mutants, suggesting that these mutants were generated by loss of the whole chromosome 11 through mitotic non-disjunction. Chromosome painting analysis supported this hypothesis; there were no mutants showing structural changes such as deletions or translocations involving chromosome 11. In contrast, spontaneous TK mutants followed from point mutations, deletions and recombinational events as well as whole chromosome loss. Our present study indicates that spindle poisons induce mutations through mitotic non-disjunction without structural DNA changes and supports a possible mechanism in which a recessive mutation mediated by aneuploidy may develop tumors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11516720     DOI: 10.1016/s1383-5718(01)00167-x

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  7 in total

1.  In vivo pig-a and micronucleus study of the prototypical aneugen vinblastine sulfate.

Authors:  Svetlana L Avlasevich; Carson Labash; Dorothea K Torous; Jeffrey C Bemis; James T MacGregor; Stephen D Dertinger
Journal:  Environ Mol Mutagen       Date:  2017-08-19       Impact factor: 3.216

2.  Endoreduplication in conjunction with tumor progression in an aneuploid laryngeal squamous cell carcinoma.

Authors:  Michael J Schwerer; Jörg Hemmer; Klaus Kraft; Heinz Maier; Peter Möller; Thomas F E Barth
Journal:  Virchows Arch       Date:  2003-05-15       Impact factor: 4.064

3.  Comparative Genotoxicity of TEMPO and 3 of Its Derivatives in Mouse Lymphoma Cells.

Authors:  Xiaoqing Guo; Ji-Eun Seo; Steven M Bryce; Jenna A Tan; Qiangen Wu; Stacey L Dial; Martha M Moore; Nan Mei
Journal:  Toxicol Sci       Date:  2018-05-01       Impact factor: 4.849

4.  Mechanistic evaluation of Ginkgo biloba leaf extract-induced genotoxicity in L5178Y cells.

Authors:  Haixia Lin; Xiaoqing Guo; Suhui Zhang; Stacey L Dial; Lei Guo; Mugimane G Manjanatha; Martha M Moore; Nan Mei
Journal:  Toxicol Sci       Date:  2014-03-04       Impact factor: 4.849

5.  Nitroxide TEMPO: a genotoxic and oxidative stress inducer in cultured cells.

Authors:  Xiaoqing Guo; Roberta A Mittelstaedt; Lei Guo; Joseph G Shaddock; Robert H Heflich; Anita H Bigger; Martha M Moore; Nan Mei
Journal:  Toxicol In Vitro       Date:  2013-03-18       Impact factor: 3.500

6.  Long-term colchicine therapy in a patient with Behçet's disease and acute promyelocytic leukemia.

Authors:  Hakan Ozdogu; Can Boga; Zerrin Yilmaz; Feride Iffet Sahin; Nebil Bal
Journal:  Rheumatol Int       Date:  2006-12-20       Impact factor: 3.580

7.  Microarray analysis distinguishes differential gene expression patterns from large and small colony Thymidine kinase mutants of L5178Y mouse lymphoma cells.

Authors:  Tao Han; Jianyong Wang; Weida Tong; Martha M Moore; James C Fuscoe; Tao Chen
Journal:  BMC Bioinformatics       Date:  2006-09-06       Impact factor: 3.169

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.